scispace - formally typeset
G

Guillermo Garcia-Garcia

Researcher at University of Guadalajara

Publications -  139
Citations -  6984

Guillermo Garcia-Garcia is an academic researcher from University of Guadalajara. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 30, co-authored 131 publications receiving 5427 citations. Previous affiliations of Guillermo Garcia-Garcia include The George Institute for Global Health & University of Cincinnati.

Papers
More filters
Book ChapterDOI

Raising Awareness: The World Kidney Day Initiative

TL;DR: After 11 years from its inception WKD has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public, health professionals, and decision-makers on the importance of prevention and treatment of kidney disease.

World Kidney Day 2015: CKD in Disadvantaged Populations

TL;DR: Guillermo GARCIA-GARCIA 1 and Vivekanand Jha ; on behalf of the World Kidney Day Steering Committee * 1 Nephrology Service, Hospital Civil de Guadalajara, University of Guadalaez Health Sciences Center, Guadalajaara, Jal. Mexico 2 Postgraduate Institute of Medical Education and Research, Chandigarh, India, George Institute for Global Health, New Delhi, India and University of Oxford, United Kingdom
Journal ArticleDOI

MO309: Serum Sodium Trajectory During AKI and Mortality Risk

TL;DR: Uncorrected hypernatremia was associated with death, and uncorrected hyponatremiawas correlated with the need for kidney replacement therapy, and most patients with acute kidney injury had alterations in serum sodium.
Journal ArticleDOI

Effect of Cognitive Behavioral Intervention Combined with the Resilience Model to Decrease Depression and Anxiety Symptoms and Increase the Quality of Life in ESRD Patients Treated with Hemodialysis

TL;DR: In this article , the effect of cognitive behavioral intervention combined with the resilience model (CBI + R) vs CBI alone on depression symptoms, anxiety symptoms, and quality of life of end-stage renal disease (ESRD) patients undergoing hemodialysis replacement therapy was compared.